Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activities.

[1]  K. Gelmon,et al.  Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials. , 2012, Cancer treatment reviews.

[2]  P. Balakumar,et al.  Submaximal PPARγ activation and endothelial dysfunction: new perspectives for the management of cardiovascular disorders , 2012, British journal of pharmacology.

[3]  F. Shojaei,et al.  Anti-angiogenesis therapy in cancer: current challenges and future perspectives. , 2012, Cancer letters.

[4]  K. Node,et al.  Endothelial dysfunction as a cellular mechanism for vascular failure. , 2012, American journal of physiology. Heart and circulatory physiology.

[5]  K. Kiura,et al.  Targeting angiogenesis in cancer therapy. , 2011, Acta medica Okayama.

[6]  Huidong Shi,et al.  Loss of Methyl-CpG–Binding Domain Protein 2 Enhances Endothelial Angiogenesis and Protects Mice Against Hind-Limb Ischemic Injury , 2011, Circulation.

[7]  T. Münzel,et al.  Oxidative stress and endothelial dysfunction in hypertension , 2011, Hypertension Research.

[8]  K. Muta,et al.  Loss of Jak2 Selectively Suppresses DC-Mediated Innate Immune Response and Protects Mice from Lethal Dose of LPS-Induced Septic Shock , 2010, PloS one.

[9]  R. Torres,et al.  The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure , 2010, Nature Medicine.

[10]  A. Verin,et al.  Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of Sp1 activity. , 2009, DNA and cell biology.

[11]  J. She,et al.  Extracellular High-Mobility Group Box 1 Acts as an Innate Immune Mediator to Enhance Autoimmune Progression and Diabetes Onset in NOD Mice , 2008, Diabetes.

[12]  S. Wedgwood,et al.  Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of AP-1 activity. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[13]  M. Q. Kemp,et al.  Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene , 2008, Breast Cancer Research.

[14]  F. Kabbinavar,et al.  Angiogenesis and angiogenic inhibitors in renal cell carcinoma , 2008, Current urology reports.

[15]  Pimonrat Ketsawatsomkron,et al.  Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation. , 2007, American journal of physiology. Heart and circulatory physiology.

[16]  A. Bhandoola,et al.  Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. , 2007, Cell stem cell.

[17]  J. Ihle,et al.  Jak2: normal function and role in hematopoietic disorders. , 2007, Current opinion in genetics & development.

[18]  O. Silvennoinen,et al.  The Janus kinases (Jaks) , 2004, Genome Biology.

[19]  H. Rui,et al.  Generation of a conditional knockout allele for the Janus kinase 2 (Jak2) gene in mice , 2004, Genesis.

[20]  M. Medina,et al.  Angiogenesis and signal transduction in endothelial cells , 2004, Cellular and Molecular Life Sciences CMLS.

[21]  R. Kaufmann,et al.  Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription , 2003, Journal of Cell Science.

[22]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[23]  P. Shaw,et al.  PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway , 2002, Oncogene.

[24]  M. Goldsmith,et al.  JAK/STAT signaling by cytokine receptors. , 1998, Current opinion in immunology.

[25]  G. Müller,et al.  Regulation of Raf‐1 kinase by TNF via its second messenger ceramide and cross‐talk with mitogenic signalling , 1998, The EMBO journal.

[26]  M. Marrero,et al.  Role of Janus Kinase/Signal Transducer and Activator of Transcription and Mitogen-activated Protein Kinase Cascades in Angiotensin II- and Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Proliferation* , 1997, The Journal of Biological Chemistry.

[27]  K. Arai,et al.  Roles of the JAK-STAT system in signal transduction via cytokine receptors. , 1996, Current opinion in genetics & development.

[28]  P. Dent,et al.  Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation , 1996, Molecular and cellular biology.

[29]  L. Ghiadoni,et al.  Hypertension and endothelial dysfunction: therapeutic approach. , 2012, Current vascular pharmacology.

[30]  Tiffany A. Wallace,et al.  A True Jak of All Trades , 2004 .

[31]  B. Zetter,et al.  Cell motility in angiogenesis and tumor metastasis. , 1990, Cancer investigation.

[32]  H. Shepard,et al.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.